PTM BIO

Since its inception in 2010, PTM BIO has consistently been at the forefront of innovation in the realms of biological reagents and proteomics. Our commitment to pioneering technologies is driving advancements in the study of protein post-translational modification (PTM) and epigenetics, effectively meeting the critical needs in these specialized fields. Our integrated platform combines exclusive PTM reagents, IVD raw materials, advanced mass spectrometry proficiency, and state-of-the-art bioinformatics tools to redefine the landscape of biomedical and pharmaceutical research. PTM BIO is devoted to developing and offering groundbreaking research products and services, revolutionizing the way we comprehend, diagnose, and combat human diseases. Explore more about PTM BIO at www.ptmbio.com.